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ABSTRACT

SYNTHESIS, CHARACTERIZATION, DNA BINDING AND

PHOTOACTIVITY

OF DIRUTHENATED C/S-5,10-(4-PYRIDYL)-15, 20-(PENTAFLUOROPHENYL)
PORPHYRIN.

Beeram Sandya Rani
University of Dayton
Advisor: Dr. Shawn. M. Swavey

The

5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin

porphyrin

synthesized

by

refluxing

a

solution

of

(I)

pentafluorobenzaldehyde,

was
4-

pyridinecarboxaldehyde and pyrrole in propionic acid. The separation of c/sporphyrin (I)

from a mixture of six porphyrins was achieved by column

chromatography.

The

porphyrin

[5,10-(4-pyridyl)-15,20-(pentafluorophenyl)

porphyrin Ru2(bipy)4Cl2](PF6)2 (II) was synthesized by reacting c/s-porphyrin (I)

with c/s-Ru(bipy)2Cl2 in glacial acetic acid. Electronic transitions associated with

c/s-porphyrin (I) consist of an intense Soret band at 410 nm and three Q bands
from 500-650 nm. Coordination of [Ru(bipy)2CI]+ groups to the pyridyl nitrogens of

the porphyrin give additional electronic transitions associated with bipy orbitals
and metal to ligand charge transfer (MLCT) transitions attributed to Ru(II) and

iii

bipy orbitals.

The

cyclic voltammogram

of c/s-porphyrin

(I)

shows two

quasireversible redox couples in the cathodic region which occur at E1/2 = -0.86 V
and -1.26 V versus Ag/AgCI reference which are shifted to slightly more positive
potentials when the porphyrin is

coordinated to the Ru(II) groups. Ruthenium

porphyrin (II) shows a quasireversible redox couple in the anodic region at 0.83

V versus Ag/AgCI attributed to Ru(lll/Il) couple. Spectroscopic titrations were

performed with calf thymus DNA to determine a binding constant (Kb) for c/'s-

porphyrin (I) and ruthenium porphyrin (II). A binding constant of 7.6 x 105 M'1
was determined for ruthenium porphyrin (II) and a value of 2.0 x 104 M'1 was

determined for the c/s porphyrin (I). Irradiation of aqueous buffered solutions of
circular plasmid DNA and the ruthenium porphyrin (II) complex with a 50 W

tungsten-halogen lamp indicate, by gel electrophoresis, that light induced DNA
photocleavage occurs.

iv
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CHAPTER 1

INTRODUCTION

There has been a growing interest in Photodynamic therapy (PDT) as a

treatment modality to destroy cancer cells.1 The first clinical application of PDT

occurred in 1900 when Oscar Rabb, a medical student working with professor

von

Herman

Tappeiner noted that

paramecium caudatum cells died quickly

when exposed to light in the presence of acridine orange.2 In 1903, Jesionek
and Tappeiner treated skin cancer with light and eosin.3 In these instances
orange and eosin act as photosensitizers. In 1913, Meyer-Betz

acridine

observed the photosensitizing effects of porphyrins in man by injecting himself
intravenously with

hematoporphyrin and noticed pain and swelling in the light

exposed area.4 The structures of the early photosensitizers are illustrated in
Figure 1.

Acridine
Figure 1: Early photosensitizers.

Hematoporphyrin

The uptake of

visualized by Policard

porphyrins in significant amounts by tumors was first
in 1924 when

he observed the characteristic red

fluorescence of hematoporphyrin in experimental rat
ultraviolet light.5 Together

with Jadlbauer,

sarcoma illuminated with

von Tappeiner went

on to

demonstrate the requirement of oxygen in photosensitization reactions and in
1907 introduced the term “photodynamic action” to describe the phenomenon.6

Three fundamental requirements for PDT are light, molecular oxygen

and a

photosensitizer. Each factor is harmless by itself but the combination of

all three factors can result in the production of lethal cytotoxic agents that can

destroy cancer cells.1

REACTION MECHANISMS OF PDT:

Porphyrin
Sensitizer

Molecular
Oxygen

Figure 2: Jablonski diagram.
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The photochemical and photophysical principles of PDT are schematically

represented in the modified Jablonski diagram, (Figure 2).7 The photosensitizer
has no effect on the tissue unless it is activated by light of an appropriate
wavelength. The photosensitizer absorbs a photon of energy from the light

source. Once it has absorbed energy the excited photosensitizer can return to

the ground state by a number of pathways. A good photosensitizer at this stage
undergoes intersystem crossing to get rapidly converted to the long lived triplet

state. There are two mechanisms by which the triplet state photosensitizer can
react with biomolecules; these are known as the Type I and Type II reactions. In

Type I reactions there might be an hydrogen atom abstraction or electron
transfer reaction between the excited state of the sensitizer and the substrate to

yield radicals and radical ions. Since these radical species are highly reactive
they can interact with molecular oxygen

to generate reactive oxygen species

(ROS) such as superoxide anion, hydrogen peroxide and

hydroxyl radicals.

Type II reactions produce an excited and highly reactive state of oxygen known
as singlet oxygen. Direct interaction of the excited triplet state photosensitizer

with molecular oxygen results in formation of reactive singlet oxygen. Singlet
oxygen and ROS are oxidizing molecules that can readily react with biological
molecules and they can oxidatively modify selected amino-acid residues,

unsaturated lipids or damage DNA.8 Type II reactions are reported to dominate
during PDT. However Type I reactions may become more dominant under
conditions where photosensitizers are highly concentrated, and especially under
hypoxic conditions.9 These reaction types are illustrated in scheme 1.

3

Scheme 1: Type I and Type II Reactions

Type I Reactions:

C1)

3P* + S ----------- ► P + S+

+ O2

followed by

SOx

(2)

or

P~ + O2---------- ► Po + 67
O2 + S

(3 )

► ^ox

In both cases giving an oxidized biomolecule Sox.

An alternate type I reaction pathway might be

followed by

3P*+ 3o2 -------- P + O2
+
•+
P + S --------- ► Po+ S

(5)
(6)

Reaction (4) may follow after reaction (5) and reaction (2) may follow after
reaction (6).

Type II Reactions:
3p* _|_ 3q^--------- ► Po + !O2

'o2 + S ------ *•

sox

The first sensitizer used in clinical PDT was a Hematoporphyrin derivative
and its purified fraction Photofrin HpD. Photofrin® has passed the clinical trials
and it was the first PDT agent approved by FDA for treating esophageal cancer
and is currently used to treat a wide variety of cancers.10 Photofrin® is a mixture
containing hematoporphyrin, hydroxyl ethyl vinyl deuteron porphyrin (HVD) and

4

protoporphyrin (Pp) as well as complex dimeric and oligomeric fractions.11 It has

low

quantum yields and low efficiency in the generation of reactive oxygen

species. It results in prolonged skin photosensitivity lasting for 6-8 weeks.12 It is
excited with red light at 630 nm. This wavelength can penetrate tissue to a depth

of few mm and hence is

unsuitable for treating deep seated tumors. New

photosensitizers, so called “second generation” photosensitizers have been

synthesized

have

that

better

properties

than

Photofrin®.

Chlorins

and

Bacteriochlorins are a group of molecules very similar to porphyrins which were
found to be effective photosensitizers in cancer prevention.13 In chlorins one of

the exopyrrole double bonds of the porphyrin ring

is hydrogenated and in

bacteriochlorins, two of the exopyrrole double bonds of the porphyrin ring are

hydrogenated thus enabling maximum absorption at longer wavelengths. The
core structures of porphyrin, chlorin and bacteriochlorin are illustrated in Figure 3.

Porphyrin
Figure 3: The
bacteriochlorins.

basic

bacteriochlorin

Chlorin

chemical

structures

5

of

porphyrins,

chlorins

and

Temoporfin or tetra (m- hydroxyl-phenyl) chlorin, Figure 4 under the trade

name Foscan™ is a potent photosensitizer available for clinical use at present.
This drug was approved by the European Union for the treatment of head and

neck cancers in 2001. It is 200 times more effective than Photofrin®. It is
activated with a longer wavelength and lower light intensity compared to
Photofrin® and also has a longer half life in the triplet state generating more

cytotoxic oxygen species.14 Foscan is also in clinical trials for late stage
esophageal cancer and dysplasia in Barrett’s esophagus.15 It is more selective
between tumor and normal tissue.

Figure 4: Structure of m-tetra hydroxyl phenyl chlorin.

Verteporfin (benzo-porphyrin-derivative mono-acid ring A), Figure 5, which
is a chlorin type molecule under the trade name Visudyne™ is in Phase III

clinical trials for cutaneous non-melanoma skin

cancer and Phase I/II

trials

against non-melanoma skin cancers (such as multiple non-melanoma

skin

cancer)16, psoriasis17 and psoriatic and rheumatoid arthritis. It has rapid tumor

accumulation and reduced skin photosensitivity.18

6

H3CO2C
h3cc

o
Figure 5: Structure of Verteporfin.

Pthalocyanines have emerged to be a promising class of second

generation photosensitizers.19 The core consists of a tetra pyrrole unit, but in

contrast to porphyrin, the pyrrole subunits are linked by nitrogen atoms rather
than by methine bridges. This causes absorption spectrum to shift to longer

wavelengths

and

hence

increased

tissue

penetration.20

Incorporation

of

diamagnetic metals (Zn, Al) enables longer triplet state life times increasing the

efficiency of the formation of reactive oxygen species. The basic structure of
pthalocyanines is represented in Figure 6.

R

R

R

Figure 6: Structure of pthalocyanines.
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Levulan (5-Aminolaevulinic Acid) has passed the clinical trials. It is a metabolic
precursor in the biosynthesis of haem. Protoporphyrin IX (PplX) which is a

natural photosensitizer is the immediate precursor to haem in this pathway. The

rate of formation of PplX depends on the rate of synthesis of 5-Aminolaevulinic
Acid (ALA) from glycine and succinyl CoA which is governed in negative

feedback manner by concentration of free haem. The external addition of excess

ALA can bypass this negative feedback, leading to a buildup of PplX, an effective
photosensitizer for PDT.21

co2h

5-Aminolaevulinic acid

Protoporphyrin IX

Figure 7 : 5- Aminolaevulinic acid (ALA) and Protoporphyrin IX.

The potential of porphyrins as anti tumor agents in oncology was first fully
recognized in the 1960s with the development of hematoporphyrin derivative

(HpD),which showed selective localization in solid tumors.22 Porphyrins are
strongly colored compounds, the color is due to their electronic structure resulting
in less intense absorptions at longer wavelengths (450 to 700 nm) in the visible

region (called Q bands) and strong intense absorption in the near Ultra Violet

8

region in the neighbourhood of 400 nm (called the Soret band). In 1884, Nencki
isolated the first pure porphyrin by preparing Hematoporphyrin hydrochloride
directly from isolated heme.23

In 1912, Kuster first proposed the structure of

porphyrins as four pyrrole units linked by four methine bridges.24 The parent form

of these tetrapyrrolic macrocycles is known as “porphine”, Figure 8.

Figure 8: Porphine: The parent form of tetrapyrrolic macrocycle.

In 1975, Dougherty demonstrated HpD could selectively destroy tumors
upon irradiation.25 Porphyrins were used as ideal photosensitizers because they
generate singlet oxygen and have maximum absorption in the red portion of the

electromagnetic spectrum which results in maximum penetration of light into the

tissue.8 Most porphyrinoid photosensitizers have more than one absorption band
and hence are used for tissue depth controlled penetration. In order to increase

the quantum efficiency of photosensitizers such as porphyrins, fluorinated
porphyrin derivatives, Figure 9 have been used. Enhanced triplet quantum yields

are observed for fluorinated porphyrins which make them ideally suited to act as
photosensitizers in photodynamic therapy.26 In addition to increased quantum

efficiency pentafluorophenyl substituents have been utilized to covalently link

sugars to porphyrins which improves the cell uptake.27

9

Figure 9: Structure of tetra-pentafluorophenyl porphyrin.

Metal complexes represent a promising field in the discovery of new PDT

agents since they react with double stranded DNA directly from their excited
state28,29 or via the production of various reactive species such as OH‘, O2" or

1O2.30'31'32

Some examples of metal complexes that cleave DNA upon irradiation

include mono nuclear Re(I)33, Ru(II)28, and Rh(III)34 complexes, dinuclear

rhodium(II,II)35 and trinuclear Ru(II)-Rh(III)-Ru(II)36 complexes. The three main
properties that make ruthenium complexes well suited to medicinal application
are their rate of ligand exchange, range of accessible oxidation states and the

ability of ruthenium to mimic iron in binding to certain biological molecules.37

Intercalators are small molecules that contain a planar aromatic heterocyclic
functionality which can insert and stack between the base pairs of double helical

DNA.38 The early studies describing the intercalation of coordinatively saturated
octahedral transition-metal complexes with DNA focused on the binding of

tris(phenanthroline) complexes of zinc, cobalt and ruthenium to DNA, Figure
10.39 Studies with these simple metal complexes

10

provided

a

basis for

understanding how octahedral complexes might interact noncovalently with DNA
and also for exploring how the photophysical and redox characteristics of the

metal complexes might be utilized in developing new probes for DNA.

2+

[R.u(tetra methyl phen)3]2+
Figure 10: Early octahedral DNA probes.

Increasing the surface area for intercalative stacking by a complex leads
to an increase in intercalative binding affinity. Bipyridyl and phenanthroline
complexes of ruthenium containing the dipyrido[3,2-a:2’,3’-c]phenazine (dppz)

ligand show good intercalation into the DNA.40 The dppz complexes, with their

large aromatic surface area show extremely high affinity for DNA, with binding
constants

>

106

M'141

tetraazaphenanthrene

ruthenium

Analogous

(TAP),

complexes,

1,4,5,8,9,12-hexaazatriphenylene

with

1,4,5,8-

(HAT)

also

interact with DNA and like dppz complexes, show changes in photophysical

properties upon binding to the DNA duplex.42 Bimetallic complexes bridged by
the 2,3-bis(2-pyridyl)-benzo quinoxaline (dpb) ligand have also been shown to

bind to DNA by intercalation.43 The structures of dppz, TAP, HAT and dpb are
illustrated in the Figure 11.
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dpb
Figure 11: Intercalating ligands.

Porphyrins containing meso substituted pyridyl groups are very well suited

to coordinate metal complexes at the porphyrin periphery.44 The advantages of
using polypyridyl ruthenium (II) substituents covalently linked to porphyrins are
the added water solubility and the ability of ruthenium (II) polypyridyl complexes

to intercalate and oxidize DNA bases resulting in decomposition 45 The present
describes

thesis

the

of

synthesis

5,10-(4-pyridyl)-15,20-

(pentafluorophenyl)porphyrin [Figure 12(1)] and its ruthenium (II) analog [Figure

12(11)].

Characterization of these complexes

is accomplished

by

UV-Vis

spectroscopy, cyclic voltammetry, 1H NMR, time-of-flight mass spectrometry and
elemental analysis. UV-Vis titrations of these porphyrins with calf thymus (CT)

DNA were

performed

to

determine

12

the

binding

constant.

Agarose

gel

electrophoresis was performed to determine the photocleavage of circular
plasmid (pUC18) DNA by ruthenium porphyrin [Figure 12(H)] after irradiation with
a 50 W tungsten-halogen lamp.
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CHAPTER 2

EXPERIMENTAL SECTION

Materials
All

reagents were analytical grade

pyridinecarboxaldehyde,

unless

pentafluorobenzaldehyde,

mentioned otherwise. 4propionic acid,

tetrabutyl

ammonium hexafluorophosphate, TBAPF6, used as supporting electrolyte for

electrochemistry and acetonitrile (extra dry < 50 ppm water) for electrochemistry

were purchased from Acros Organics. Ammonium hydroxide, N,N’- dimethyl

formamide (DMF), methanol, acetonitrile, diethyl ether, methylene chloride,
ethanol, sea sand, glacial acetic acid and ethyl acetate were used from Fisher
Scientific. (60-200 mesh) silica gel was obtained from Sorbent Technologies.

Ruthenium (III) chloride

trihydrate and 2,2’-bipyridine were obtained from

Aldrich. Pyrrole (Aldrich) was vacuum distilled prior to use and all other reagents
were used without further purification.
Atlantic Microlab,

Norcross, Ga.

Elemental analyses were performed by

High resolution mass spectroscopy was

performed at the Mass Spectrometry and Proteomics facility, The Ohio State
University.

Solution Electrochemistry
Solution cyclic voltammograms were recorded using a one compartment, three

electrode cell, (model 630A Electrochemical analyzer from CH-lnstruments)

14

equipped with a platinum wire auxiliary electrode. The working electrode was a

2.0 mm diameter glassy carbon electrode from CH-lnstruments. The working
electrode was polished initially using 0.30 p followed by 0.05 p alumina polish

(CH-lnstruments) and then sonicated in distilled water for 5 sec prior to use.

Potentials were referenced to a Ag/AgCI electrode, CH-lnstruments. The
supporting electrolyte was 0.1 M tetrabutyl ammonium hexafluorophosphate

(TBAPF6) and the measurements were made in extra dry, < 50 ppm water,
acetonitrile.

Electronic Spectroscopy
UV-Vis spectra were recorded at room temperature using a Schimadzu

1501 photodiode array Spectrophotometer with 2 nm resolution. Samples were
run in UV-grade CH3CN in 1 cm quartz cuvettes.

Proton NMR Spectroscopy
1H NMR spectra were recorded on a Bruker 300 MHz spectrophotometer

using deuterated chloroform (CDCI3) as the solvent and tetramethylsilane (TMS)
as the internal standard.

Synthesis
c/s-Ru(bipy)?CI?:46

Bipyridine (3.00 gm, 19.0 mmoles) was dissolved initially in 15 mL of DMF

and 2.80 gm (66.5 mmoles) of lithium chloride was added followed by 2.50 gm
(9.50 mmoles) of RuCI3-3H2O and the reaction mixture was heated at reflux for 8

15

hours. The mixture was cooled to room temperature and poured into rapidly
stirred 50 mL of acetone and the flask was rinsed with 2x12 mL portions of
acetone. The mixture was cooled overnight and filtered

giving a black/red

powder which was sonicated in approximately 50 mL water and filtered again

giving a microcrystalline powder which was washed with water until the filtrate

was no longer orange followed by 3x20 mL diethyl ether and air dried. The
product yield was 1.60 g (9.50 mmoles, 51 % yield).

5,10-(4-pyridyl)-15,2Q-(pentafluorophenvl)porphyrin

\(cis- H?(DPyFP)1

A solution containing 1.9 mL (15 mmoles) of pentafluorobenzaldehyde and

4.3 mL (45 mmoles) 4-pyridine carboxaldehyde in 100 mL of propionic acid was
heated at reflux for 5 min. Freshly distilled pyrrole (4.2 mL, 60 mmoles) was
added to this solution and the reaction mixture was heated at reflux for 2 hr.

Upon cooling to room temperature the solution was divided into two fractions and
each fraction was neutralized by cautious addition to a

100 mL 50:50

methanol/ammonium hydroxide solution cooled in an ice bath. The slurry from

both fractions was combined and allowed to precipitate for one day. The slurry

was filtered and allowed to air dry. The fine powder was dissolved in 70-100 mL

of ethanol and filtered and the precipitate was allowed to air dry. The powder was
dissolved in methylene chloride and chromatographed on silica gel using ethyl
acetate and ethyl alcohol in the ratio 50:50 as the eluent. The first band that

came off the column was 5,15-(4-pyridyl)-10,20-(pentafluorophenyl)porphyrin.
The second band was 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin. The
third band that came off the column was tri-pyrido mono-pentafluorophenyl
16

porphyrin. The second band which was the desired band was collected and the

solvent was removed by allowing it to evaporate. The product yield was 57.0 mg.
(0.070 mmoles, 0.47% yield). Rf (ethyl acetate/ethanol 50:50) = 0.61.
UV-Vis (CH3CN) Amax (nm) [e x 10'4 (M’1 cm’1)] 410 [18.9], 507 [1.5], 581 [0.62],

648 [0.26]. 1H NMR (300 MHz, CDCI3, TMS): 5 9.09 (4H, dd, 2,6-pyridyl), 8.90

(4H, d, pyrrole), 8.86 (4H, d, pyrrole), 8.20 (4H, dd, 3,5-pyridyl), -2.92 (2H, s,
internal pyrrole). [C42H18N6F10- 1C2H5OH] Anal Calcd (%): C, 62.71; H, 2.87; N,

9.97;

Found:

C,

62.54;

H,

3.05;

N,

9.86%.

TOF-MS

ES+(m/z;

relative

abundance): [ C42Hi7N6F10]+ (796; 100).

[5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin
H2(DPyFP)Ru2(bipv)4Cl2l(PFg)?

Ru2(bipy)4CI21(PF6)2

[C/s-

A solution of 0.050 g (0.063 mmoles) of c/s-5,10-(4-pyridyl)-15,20-

(pentafluorophenyl)porphyrin and 0.058 g (0.12 mmoles) of c/s-Ru(bipy)2CI2 was
heated at reflux under nitrogen in 5 mL of glacial acetic acid for 45 min. The
glacial acetic acid was removed under reduced pressure and the residue was

taken up in a minimum (5 mL) of methanol and heated at reflux for 45 min. The
reaction mixture was added dropwise to 60 mL of an aqueous solution of

saturated ammonium hexafluorophosphate. The precipitate was filtered and
washed with water. The powder was taken up in a minimum (5 mL) of
acetonitrile and flash precipitated by addition to 100 mL of diethyl ether with

stirring. The product was filtered and dried. The product yield was 0.050 gm.
(0.025 mmoles, 40% yield). UV-Vis (CH3CN) Amax (nm) [e x 1CT4 (M‘1 cm’1)] 294

[9.6], 411 [13.9],507 [2.8], 583 [0.9], [CszHsoN^C^Ri^- 4H2O] Anal Calcd
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(%): C, 47.44; H, 2.71; N, 9.19; F, 20.03; Found: C, 47.30; H, 2.51; N, 9.37; F,
19.83%. TOF-MS ES+ (m/z; relative abundance): [C82H5oNi4F22Cl2P2Ru2]+ (1839;
46).

DNA INTERACTIONS
Materials:
Electrophoresis-grade

low

EEO

agarose,

tris(hydroxymethyl)-

aminoethane (Tris), sodium chloride, and boric acid were obtained from Fisher.

The plasmid, pUC18, was obtained from Bayou Biolabs. Ethidium bromide was

obtained from EM. Agarose gel 6X loading dye was used to prepare the samples
for loading on gel. The spectroscopic titration was carried out at room

temperature in the buffer (5 mM Tris, 0.1 M NaCI, pH 7.16). Concentration of the
calf thymus (CT) DNA (Sigma) solution used in titrations was determined

spectrophotometrically using the extinction coefficient 6600 M'1cm'1at 260 nm.47
All aqueous solutions were prepared using doubly distilled water. APEX

illuminator (Oriel Inst., New port) was used to irradiate the samples. Electronic
UV transilluminator (ULTRA. LUM. INC) was used for viewing DNA in agarose

gels stained with ethidium bromide. Incubator (Barnstead labline) was used to

incubate the samples in the experiments which were run in the dark. The pH of
the solutions was measured using a

Denver instruments pH meter.
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DNA binding titrations
Preparation of buffer (5 mM Tris, 0.1 M NaCI): 0.0610 g of tris(hydroxymethyl)aminoethane (Tris) and 0.584 g of sodium chloride were weighed and dissolved

in 100 mL of deionized water. The pH of the buffer was measured to be 7.16.

CT DNA was dissolved in buffer and the concentration of this solution was
determined spectrophotometrically using the extinction coefficient 6600 M'1cm'1at

260 nm giving a concentration of 330 pM.
A stock solution of ruthenium porphyrin (II)

(19.5 pM) in 10% DMSO /H20

was diluted to 9.75 pM using the Tris buffer solution. For DNA titrations 3.5 mL of

the diluted ruthenium porphyrin was placed in a 1 cm quartz cuvette. Aliquots (10
pL) of the CT-DNA solution were added to the cuvette and the Soret band

associated with the ruthenium porphyrin (n)

was monitored. Additions were

made until the spectra did not change or the solution became turbid.

Photocleavage of circular plasmid DNA:

The5XTB buffer used for electrophoresis was prepared by dissolving 27.5 g
Boric acid and 54.0 g Tris base in 1 L volumetric flask with deionized water.

Preparation of agarose gel:
To 0.8 g of agarose weighed accurately , 80 mL of doubly distilled water
was added and heated in a microwave for 2.5 min on low power. 20 mL of 5X TB

buffer was added and swirled to mix well and then this liquid agarose solution

was poured into the gel rig tray. An appropriate size comb was inserted into the
liquid agarose and the gel was allowed to solidify. Once the gel solidified the
buffer solution was added. The buffer was prepared by obtaining 150 mL of 5X
19

TB buffer and diluting to 600 mL with doubly distilled water and then poured over
the solidified gel.

Preparation of the metal complex:

10.1 pM ruthenium porphyrin (II) in 10 % DMSO was prepared and used for
photocleavage studies.

Two solutions were prepared in 1.5 mL eppendorf tubes which includes

one for control (DNA with no metal complex added) and other for the test (DNA
with metal complex). 5 pL of 1 pg/1 pL pUC 18 DNA was added to both tubes. An
appropriate amount of metal complex solution was added to the test solution to

give the desired 5 DNA BP:metal complex ratio. An appropriate amount of doubly
distilled water was added to both tubes to bring the final volume to 500 pL. Both

tubes were vortexed and then spun in a centrifuge for 30 seconds. The control

and test solutions were transferred to quartz cuvettes and placed side by side
and irradiated with a 50 W tungsten halogen lamp from an APEX illuminator. At

0, 30, 60, 90 and 120 minute time intervals 20 pL aliquots were pipetted into the
eppendorf tubes. 4 pL of 6X loading dye was pipetted into each tube and all the

10 tubes were vortexed and spinned in the centrifuge. The samples were then
loaded onto the agarose gel and subjected to 150 V voltage for 1 hour. The gel

was then soaked in ethidium bromide staining solution for 1 hour. The ethidium

bromide staining solution was prepared by adding 30 pL of ethidium bromide to
250 mL

of deionized water and mixing well. The gel was then photographed

using UV illumination.
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To reveal the importance of light, experiments were run in the absence

and presence of light and a comparision was made. In this study two sets of
solutions were prepared. Each set consists of a control and a test solution. 5 pL

of pUC 18 DNA was added to both control and test solution. An appropriate
amount of metal complex solution was added to the test solution to give the

desired 5 DNA BP:metal complex ratio. Appropriate amount of doubly distilled
water was added to both control and test solutions to bring the final volume to
500 pL. Then one set of solutions was placed in an incubator at 37°C for 2 hours

and the other set was irradiated for 2 hours with a 50 W tungsten halogen lamp
from an APEX illuminator. The samples were loaded onto agarose gel and

subjected to an electric field by applying 150 V voltage for 1 hour. The gel was

then soaked in ethidium bromide staining solution for 1 hour and photographed
using UV illumination.
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CHAPTER 3

RESULTS AND DISCUSSION

Synthesis and characterization

The

c/s-porphyrin

pentafluorobenzaldehyde,

(I)

was

by

synthesized

4-pyridinecarboxaldehyde

and

reaction

pyrrole

in

of

the

stoichiometric ratio 1:3:4 respectively in refluxing propionic acid, Figure 13.

Figure 13: Synthesis of 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin.

The major product of this reaction is the polymeric material while the minor
product is the formation of c/s-porphyrin (I) along with five other porphyrins,

Figure 14. Attempts to increase the yield of the c/s-porphyrin (I) by varying the

ratio of the aldehydes led to the ratio shown in Figure 13 which indicates that

pentafluorobenzaldehyde is more reactive than 4-pyridine carboxaldehyde. The
polymeric byproducts were removed by washing with ethanol.
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F

F

F

Figure 14: Six different porphyrins resulted by reacting two different aldehydes
with pyrrole in propionic acid.

Separation of the remaining six porphyrins was accomplished by column

chromatography.

Previous

attempts

chromatographic separation using

to

separate

the

six

porphyrins

by

methylene chloride:acetone as the eluent

were not successful in separating the cis/trans isomers. Hence different solvent
systems were employed to achieve the separation of the c/'s-porphyrin (I). The
crude product was dissolved in a minimal amount (ca 20 ml_) of methylene

chloride and filtered to remove insoluble materials. The product solution was
carefully added to the column and eluted with 50:50 ethyl acetate:ethanol which
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resulted in the clean separation of the cis- porphyrin (I) as the second band. The

yield of the product was very low and reported to be 0.47%.

Thin layer

chromatography was performed to determine the retention factor Rf for the cis
porphyrin (I). The c/s-porphyrin (I) being more polar than the trans isomer

possess lower Rf value (0.61) when compared to the frans-porphyrin (0.83) which
was separated as the first band during the chromatographic separation. The

mono-pyridyl tri-pentafluorophenyl porphyrin was washed along with the polymer

and the tri-pyridyl mono-pentafluorophenyl porphyrin was separated as the third
band. The cis- porphyrin (I) was characterized by 1H NMR, high resolution mass
spectroscopy and elemental analysis.

Ruthenium porphyrin (II) was synthesized by adding the c/s-porphyrin (I)
to c/s-Ru(bipy)2Cl2

in a stoichiometric

ratio 1:2

and refluxing in glacial acetic

acid, Figure15.

2+

II

Figure 15: Synthesis of [5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrinRu2(bipy)4CI2]2+
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Substitution of the ruthenium polypyridyl complex to the peripheral pyridyl

of the porphyrin involves displacement of a chloride ion from the sixth position.
Since six coordinate Ru(ll) complexes are typically substitution inert, extreme

conditions like refluxing in glacial acetic acid are required. After the acetic acid is

removed under reduced pressure the resulting reaction mixture is refluxed and

precipitated from methanol by addition of ammonium hexafluorophosphate. The
product was isolated in descent yields and was characterized by high resolution
mass spectroscopy and elemental analysis.

Electronic absorption spectroscopy:

The UV-Vis studies of the c/s-porphyrin (I) and its ruthenated analog (II)
were run in 1 cm quartz cuvettes in acetonitrile at room temperature. The UVVisible absorption spectrum of a typical porphyrin exhibits an intense absorption
at about 400 nm (the Soret band) followed by several weaker absorptions (Q

bands) at higher wave lengths from 450 to 700 nm. Comparision of the electronic

transitions of c/s-porphyrin (I) and its ruthenated analog (II) is illustrated in the

Figure 16. The c/s-porphyrin (I) (red line, Figure 16) shows an intense
absorption at 410 nm for the Soret band and three less intense Q bands at the

wavelengths

506, 581 and 648 nm. The highest energy electronic absorption

at 294 nm for the ruthenium

porphyrin (II) is assigned as a bipy (tt- it*)

intraligand charge transfer. Two shoulders at ca. 360 and 470 nm are attributed

to Ru(dTT) - bipyCrr*) metal to ligand charge transfer (MLCT) transition.
details of these transitions

and the

molar absorptivities

The

of the Soret and Q

bands of c/s porphyrin (I) and ruthenium porphyrin (II) are illustrated in Table 1.
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The electronic spectra of ruthenium porphyrin is an overlay of ruthenium spectra
and porphyrin spectra separately. This indicates that there is very little electronic
communication between ruthenium and porphyrin which would otherwise cause a

shift in the Soret band.

Figure 16: Electronic absorption spectra in acetonitrile at room temperature for
cis porphyrin (I) (red) and ruthenium porphyrin (II) (blue).
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Table 1: Electronic absorption spectroscopy results for cis porphyrin (I) and
ruthenium porphyrin (II).

Complex

^max (nm)

£ x 104 M'1cm'1

Assignment

cis porphyrin

410
506
581
648

18.9
1.5
0.62
0.26

Soret (tt Q band
Q band
Q band

Ruthenium
porphyrin

294
360
411
470
507
583

9.6
sh
13.9
sh
2.8
0.9

bipy(TT) - bipyfnr*)
Ru(dTT) - bipy(TT*)
Soret (tt - tt*)
Ru(diT) - bipy(TT*)
Q band
Q band

tt*)

Solution Electrochemistry

Solution phase cyclic voltammetry (CV) was performed using

a one

compartment, three electrode cell, equipped with a platinum wire auxiliary

electrode. The working electrode was a 2.0 mm diameter glassy carbon
electrode. Potentials were referenced to a Ag/AgCI electrode. The supporting
electrolyte was 0.1 M tetrabutyl ammonium hexafluorophosphate (TBAPF6) and

the measurements were made in extra dry, < 50 ppm water, acetonitrile, purged

with N2 to remove oxygen from the solution. The cyclic voltammograms of the cis
porphyrin (I) and its ruthenium analog (II) are illustrated in Figure 17.

When the cis- porphyrin (I) solution is cycled in the cathodic direction two

quasireversible redox couples with E1/2 = -0.86 V and -1.26 V versus Ag/AgCI are

observed. These redox couples can be associated with sequential reduction of
the porphyrin ring to form the radical anion. In the anodic direction there is a
27

weak irreversible oxidation process at Epa = 1.15 V versus Ag/AgCI due to the
porphyrin oxidation, Figure 17 (red line). Table 2 illustrates the redox potentials

and their assignments.
When the ruthenium

porphyrin (II) solution is cycled in the cathodic

direction two quasireversible

redox couples with

E1/2 = -0.80

and

-1.18

V

versus Ag/AgCI are observed which are attributed to a porphyrin centered redox

process. In the anodic direction, a quasireversible redox couple with E1/2= 0.83

V versus Ag/AgCI associated with the Ru(lll/Il) couple is observed, Figure 17 (blue
line). The redox potentials in the cathodic region for ruthenium porphyrin (II) and
c/s-porphyrin (I) are very similar to each other. This indicates the fact that there

is very little electronic communication between ruthenium and porphyrin which
would otherwise cause a greater difference in the redox potentials in the cathodic
region than what is observed.

Table 2: Redox potentials and their assignments for c/s porphyrin (I) and
ruthenium porphyrin (II).
Complex

Ei/2(V)

Assignment

C/'s-porphyrin

-0.86
-1.26

Por °'Por ’/2'

Ruthenium
porphyrin

0.83
-0.80
-1.18

Ru1"1'"’
Por °'Por -12'
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1.5

1.0

0.5

-0.5

0.0

-1.0

-1.5

E/V vs. Ag/AgCI
Figure 17: Cyclic voltammograms of cis porphyrin (I) (red) and ruthenium
porphyrin (II) (blue) in TBAPF6/Acetonitrile vs Ag/AgCI. Working electrode is
glassy carbon with a scan rate of 100 mv/s, N2 atmosphere.
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CHAPTER 4

DNA INTERACTIONS

There are several ways in which complexes can interact with DNA.

Complexes can interact with DNA by covalently binding, electrostatically binding,

groove binding

or by intercalating. Studies on several compounds of ruthenium

like [Ru(bpy)2L]2+ and

[Ru(phen)2L]2+ where L is an aromatic bidentate ligand,

indicate that these compounds bind to DNA, often in an intercalative fashion.48
DNA binding constants, Kb are the most commonly used measures of DNA

binding affinity. The association of metal complex with DNA is treated as a simple

equilibrium, as shown in equation 1, where Mf is the free complex (in this case,

ruthenium porphyrin), DNAf is free DNA, and MDNA is a bound ligand and bound
binding site.

[Mf] + [DNAf] ■<

**- [M+DNA]

Equation 1

To determine quantitatively a binding constant (Kb) for the interaction of

ruthenium porphyrin (II) with DNA, absorption titrations were used. Aqueous
solutions of ruthenium porphyrin (II) which were 5% in DMSO were titrated with

pH 7.16 buffered solutions (5 mM Tris, 0.1 M NaCI) of calf thymus (CT) DNA.
The concentration of the ruthenium porphyrin (II) was 9.75 pM and the
concentration of CT-DNA was 330 pM. 5 mM Tris, 0.1 M NaCI was used as the
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buffer solution. An aliquot of 10 pL DNA was added to the ruthenium porphyrin

(II)

and the absorbance of the Soret band was recorded. Figure 18 illustrates

the effects of additions of 10 pL aliquots of CT-DNA on the absorbance of the
Soret

band associated with ruthenium porphyrin (II). As the concentration of

CT-DNA increases the Soret band decreases and shifts to lower energy (415-

423 nm). This red shift is indicative of intercalative binding to DNA.49

Figure 18: Absorption spectra of pH 7.16 buffer solutions of ruthenium porphyrin
(II) in the presence of increasing amounts of CT-DNA. [ruthenium porphyrin (II)]
= 9.75 pM.
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The intrinsic binding constant Kb for the CT-DNA ruthenium porphyrin

interaction was determined from equation 2.50

[DNA]/ (ea- Cf) = [DNA]/ (eb- Cf) + 1/Kb(eb- Cf)
where ea = absorbance/ [ruthenium porphyrin], eb and

Equation 2
Cf are the extinction

coefficients for the fully bound form and the extinction coefficient for the free form

of ruthenium porphyrin(II),

respectively. A linear fit of the plot of [DNA]/ (ea-Cf)

versus [DNA] gives a slope of 1/(eb- ef) and an intercept of 1/ Kb(eb- ef), Figure
19. The intrinsic binding constant Kb is given by the ratio of the slope to intercept.

|DNA] x 106
Figure 19: Plot of [DNA]/(£a-£f) versus [DNA]
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This half-reciprocal absorption titration method, which has been used

successfully to determine the intrinsic Kb of molecules as hydrophobic as benzo
pyrene derivatives, was found to provide a useful route to obtain intrinsic binding

constant for the broad range of ruthenium complexes of different solubilities.51 A
value of 7.6 x 105 M'1 was

determined for ruthenium porphyrin (II) by this

method. A value of 2.0 x 104 M’1 was determined for the c/s porphyrin (I) by this
method.

The magnitude of Kb coupled with the red shift of the Soret band

suggests an intercalative process for the binding of ruthenium porphyrin (n) with
DNA.49 The greater binding constant for ruthenium porphyrin (II) compared to cis

porphyrin (I)

is most likely due to the increased charge of the complex and

therefore is an effect of increased electrostatic attraction.

Photocleavage of circular plasmid DNA

Agarose

gel

electrophoresis

was

photocleavage of circular plasmid DNA by

performed

to

determine

ruthenium porphyrin (II).

the
Gel

electrophoresis is a method for separating chemical compounds based on their
size, shape and charge. Gel electrophoresis is used to identify distinct

conformations of circular plasmid DNA. Supercoiled DNA (Form I), is the fastest
moving conformation in the gel because of its compact shape. Nicked circular
DNA (Form II) is also called relaxed circle and it is the slowest conformation of

circular plasmid in the gel. In the nicked circular DNA, the superhelical tension
relaxes and the tightly wound ball becomes a floppy circle. In electrophoresis
experiments the DNA fragments are injected into the wells in solidified agarose
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gel and subjected to an electric field. Since the DNA is negatively charged the

fragments that are loaded into a sample well at the cathode (-) end of a gel move
through the gel towards the anode (+). The mobility of DNA fragments on the gel

is dependent on the size, shape and the overall charge.
The DNA gels are made of agarose, a highly purified agar, which is

heated and dissolved in a buffer solution. The agarose molecules form a matrix
with pores. Agarose gels can be used to analyze double-stranded DNA
fragments from 70-base-pairs (bp) (3% agarose gel, w/v) to 800,000 bp (0.1%
agarose gel).52 In this project 0.8% agarose gel is used.

The solutions of circular plasmid DNA with and without ruthenium
porphyrin (II) were placed in two different quartz cuvettes and irradiated with a 50

W quartz tungsten halogen lamp for 120 minutes. At 30 min intervals aliquots of

both solutions were removed and prepared for gel electrophoresis. Figure 20
illustrates the results of the gel electrophoresis study.
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1

23456789

10

Figure 20: Gel electrophoresis results of circular plasmid DNA (pUC18) in the
presence of ruthenium porphyrin (lanes 2, 4, 6, 8, 10) and without ruthenium
porphyrin (lanes 1, 3, 5, 7, 9) irradiated with 50 W quartz tungsten halogen lamp
for 0 min (lanes 1 and 2), 30 min (lanes 3 and 4), 60 min (lanes 5 and 6), 90 min
(lanes 7 and 8) and 120 min (lanes 9 and 10).

When buffered solutions of circular plasmid DNA (pUC18) containing

ruthenium porphyrin (II) in a ratio of 5:1 bp:ruthenium porphyrin, are irradiated
with light the supercoiled DNA (Form I) is converted to nicked circular DNA (Form

II). Lanes

1, 3, 5, 7 and 9 represent buffered solutions of pUC18 without

ruthenium porphyrin (II) irradiated for 0, 30, 60, 90 and 120 min, respectively.
Lanes 2, 4, 6, 8 and 10 represent buffered solutions of pUC 18 with ruthenium
porphyrin (II) irradiated for 0, 30, 60, 90 and 120 min, respectively. Lanes 2, 4, 6,

8 and 10 illustrate a decrease of form I and an increase of form II. As the

irradiation time increases the circular DNA has been converted to nicked DNA.
After 2 hours of irradiation the plasmid DNA without ruthenium porphyrin (lane 9)
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remains unchanged while the circular plasmid DNA in the presence of ruthenium
porphyrin (II) (lanelO) has been completely converted to the nicked form (Form

II). Hence gel electrophoresis results suggests that the ruthenium porphyrin (II)

can photolytically cleave circular DNA.
A

B

C

D

Form II
Form I

Figure 21: Gel electrophoresis results both in the absence and presence of light.
Lanes A and B represent the circular plasmid DNA (pUC18) in the absence and
presence of ruthenium porphyrin respectively incubated for 2 hours at 37°C.
Lanes C and D represent the circular plasmid DNA (pUC18) in the absence and
presence of ruthenium porphyrin respectively irradiated with light for 2 hours.

To show that photocleavage of DNA requires both the ruthenium porphyrin
and light, experiments were run in which solutions of pUC18 with and without

ruthenium porphyrin (II) were irradiated for 2 hours. Simultaneously the same
solutions were incubated in the dark for 2 hours followed by gel electrophoresis,

Figure 21. Lanes A and B represent the circular plasmid DNA (pUC18) in the

absence and presence of ruthenium porphyrin (II) (5:1 bp:metal complex ratio)
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respectively, incubated for 2 hours at 37°C. Lanes C and D represent the circular

plasmid DNA (pUC18) in the absence and presence of ruthenium porphyrin (II)
(5:1 bp:metal complex ratio) respectively irradiated with 50 W quartz tungsten

halogen lamp for 2 hours. Lanes A ,B and C reveal no difference in the plasmid

DNA where as in lane D the circular plasmid DNA has been converted to the
nicked form (Form II). Hence the results reveal that the process is light induced.
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CHAPTER 5
CONCLUSIONS

This study describes the synthesis of two new complexes, 5,10-(4-pyridyl)-

(I)

15,20-(pentafluorophenyl)porphyrin

(pentafluorophenyl)porphyrin Ru2(bipy)4Cl2 (II)
complexes

by

UV-Vis

spectroscopy,

and

5,10-(4-pyridyl)-15,20-

and

characterization of these

solution

electrochemistry,

1H

NMR,

elemental analysis and high resolution mass spectroscopy. The intrinsic binding
constant (Kb) for these complexes was determined by Spectroscopic titrations

with calf thymus DNA. A value of

7.6 x 105 M'1 was

determined for the

ruthenium porphyrin (II) and a value of 2.0 x 104 M‘1 was determined for the c/s
porphyrin (I). The magnitude of Kb coupled with the red shift of the Soret band

suggests an intercalative process for the binding of these complexes with DNA.

Agarose gel electrophoresis was performed to determine the photocleavage of
circular plasmid DNA by ruthenium porphyrin (II) and the results reveal that the

ruthenium porphyrin (II) can photolytically cleave circular DNA.
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CHAPTER 6

FUTURE EXPERIMENTS

The present studies reveal

that

the ruthenium porphyrin (II) can

photolytically cleave circular DNA. Further studies are underway to synthesize a
tri-pyrido mono pentafluorophenyl ruthenated porphyrin and determine its

photolytic cleavage of circular plasmid DNA. The proposed structure of porphyrin
for future studies is illustrated in Figure 22.

Figure 22: Proposed structure of porphyrin for future study.
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